[Short-term and long-term results of treatment of chronic arteriopathies of the lower limbs with nicergoline. Importance of intensive medical therapy].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D001157:Arterial Occlusive Diseases / Q000188:drug therapy* / Q000601:surgery; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy; D001166:Arteriovenous Shunt, Surgical; D003925:Diabetic Angiopathies / Q000188:drug therapy; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D005728:Ganglia, Sympathetic / Q000601:surgery; D006801:Humans; D007866:Leg / Q000098:blood supply*; D008161:Lumbosacral Region; D008297:Male; D008875:Middle Aged; D009530:Nicergoline / Q000008:administration & dosage / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D004873:Ergolines; D009530:Nicergoline
Risultati a breve e lungo termine del trattamento delle arteriopatie croniche degli arti inferiori con nicergolina. Importanza della terapia medica intensiva.